RxDoctor Payments Data

Herbert Avart, DO

Physical Medicine and Rehabilitation · Broomall, PANPI 1861446908

Payments from drug & device makers

$1,329in general payments, 2019–2025

Across 75 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$697
  • Braeburn Inc.$244
  • Alkermes, Inc.$219
  • MDD US Operations, LLC$81
  • Orexo US, Inc.$52
  • Idorsia Pharmaceuticals US Inc$20
  • plus $17 from 1 others

What the payments were for

  • Food & beverage$1,30798%
  • Education$222%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,329 in reported general payments places this provider in the 80th percentile of 550 physical medicine and rehabilitation providers in Pennsylvania.

See all physical medicine and rehabilitation providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$20,510
Medicare patients
22
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate27$20,098
ZubsolvBuprenorphine Hcl/Naloxone Hcl33$19,806
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl231$13,505
SuboxoneBuprenorphine Hcl/Naloxone Hcl37$12,706
LunestaEszopiclone22$2,507
ComproProchlorperazine11$1,038
Buprenorphine Hcl22$655
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$575
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine21$444
Verapamil Hcl13$158
Duloxetine Hcl14$89
Diazepam62$78
Carisoprodol20$73
Hydroxyzine Pamoate14$68
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$66

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Orexo US, Inc.Zubsolv$52$19,80633 claims
Indivior Inc.Suboxone$697$12,70637 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 550 physical medicine and rehabilitation providers in Pennsylvania.

Other physical medicine and rehabilitation in Broomall

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →